bg
A

Arbutus Biopharma (ABUS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more

  • USD3.07
  • USD3.23
  • USD3.06
  • USD4.73
  • -8.00%
  • 6M
  • 892.80k
  • 812.57k
  • 599M
  • 2.71

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.